Literature DB >> 12420717

Remission of a CNS inflammatory disease accompanied by newly developed ANA and arthropathy during treatment with IFN-beta.

Anne-Christine Karow, Jürgen Braun, Peter Marx, Martin Stangel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12420717     DOI： 10.1007/s00415-002-0748-7

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  9 in total

1.  Interferon-beta1a-induced juvenile chronic arthritis in a genetically predisposed young patient with multiple sclerosis: comment on the case report by Levesque et al.

Authors:  R Russo; S Tenembaum; M J Moreno; C Battagliotti
Journal:  Arthritis Rheum       Date:  2000-05

Review 2.  Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy.

Authors:  Y Ioannou; D A Isenberg
Journal:  Arthritis Rheum       Date:  2000-07

3.  Immunoregulation and blocking antibodies induced by interferon beta treatment in MS.

Authors:  Y C Zang; D Yang; J Hong; M V Tejada-Simon; V M Rivera; J Z Zhang
Journal:  Neurology       Date:  2000-08-08       Impact factor: 9.910

4.  New onset of rheumatoid arthritis during interferon beta-1B treatment in a patient with multiple sclerosis: comment on the case report by Jabaily and Thompson.

Authors:  S Alsalameh; B Manger; P Kern; J Kalden
Journal:  Arthritis Rheum       Date:  1998-04

5.  Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b.

Authors:  L Speciale; M Saresella; D Caputo; S Ruzzante; R Mancuso; M G Calvo; F R Guerini; P Ferrante
Journal:  J Neurovirol       Date:  2000-05       Impact factor: 2.643

Review 6.  Interferon-beta1A-induced polyarthritis in a patient with the HLA-DRB1*0404 allele.

Authors:  M C Levesque; F E Ward; D R Jeffery; J B Weinberg
Journal:  Arthritis Rheum       Date:  1999-03

7.  HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients.

Authors:  B Lang; I Melchers; A Urlacher; R F Tanzi-Fetta; S Kohlbrenner; M M Tongio; H H Peter
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

8.  Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis.

Authors:  A J Coles; M Wing; S Smith; F Coraddu; S Greer; C Taylor; A Weetman; G Hale; V K Chatterjee; H Waldmann; A Compston
Journal:  Lancet       Date:  1999-11-13       Impact factor: 79.321

9.  Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus.

Authors:  L Llorente; Y Richaud-Patin; C García-Padilla; E Claret; J Jakez-Ocampo; M H Cardiel; J Alcocer-Varela; L Grangeot-Keros; D Alarcón-Segovia; J Wijdenes; P Galanaud; D Emilie
Journal:  Arthritis Rheum       Date:  2000-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.